 | • レポートコード：GIR-107A14951 • 出版社/出版日：GlobalInfoResearch / 2021年7月20日 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、コンパニオンアニマル薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コンパニオンアニマル薬品の種類別市場規模（感染症、皮膚病、痛み、整形外科疾患、行動病、その他の適応症）、用途別市場規模（犬、猫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・コンパニオンアニマル薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Zoetis、Boehringer Ingelheim、Merck Animal Health、Elanco Animal Health、Bayer Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Parnell ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：感染症、皮膚病、痛み、整形外科疾患、行動病、その他の適応症 ・用途別分析2016年-2026年：犬、猫、その他 ・コンパニオンアニマル薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・コンパニオンアニマル薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・コンパニオンアニマル薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コンパニオンアニマル薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・コンパニオンアニマル薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Companion Animal Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Companion Animal Pharmaceutical size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Companion Animal Pharmaceutical market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Companion Animal Pharmaceutical market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications
Market segment by Application, can be divided into
Dogs
Cats
Other
Market segment by players, this report covers
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Companion Animal Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Companion Animal Pharmaceutical, with revenue, gross margin and global market share of Companion Animal Pharmaceutical from 2019 to 2021.
Chapter 3, the Companion Animal Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Companion Animal Pharmaceutical market forecast, by regions, indication and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Companion Animal Pharmaceutical research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Companion Animal Pharmaceutical
1.2 Classification of Companion Animal Pharmaceutical by Indication
1.2.1 Overview: Global Companion Animal Pharmaceutical Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Companion Animal Pharmaceutical Revenue Market Share by Type in 2020
1.2.3 Infectious Diseases
1.2.4 Dermatologic Diseases
1.2.5 Pain
1.2.6 Orthopedic Diseases
1.2.7 Behavioral Diseases
1.2.8 Other Indications
1.3 Global Companion Animal Pharmaceutical Market by Application
1.3.1 Overview: Global Companion Animal Pharmaceutical Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Companion Animal Pharmaceutical Market Size & Forecast
1.5 Global Companion Animal Pharmaceutical Market Size and Forecast by Region
1.5.1 Global Companion Animal Pharmaceutical Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Companion Animal Pharmaceutical Market Size by Region, (2016-2021)
1.5.3 North America Companion Animal Pharmaceutical Market Size and Prospect (2016-2026)
1.5.4 Europe Companion Animal Pharmaceutical Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Companion Animal Pharmaceutical Market Size and Prospect (2016-2026)
1.5.6 South America Companion Animal Pharmaceutical Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Companion Animal Pharmaceutical Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Animal Pharmaceutical Market Drivers
1.6.2 Companion Animal Pharmaceutical Market Restraints
1.6.3 Companion Animal Pharmaceutical Trends Analysis
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Companion Animal Pharmaceutical Product and Solutions
2.1.4 Zoetis Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Zoetis Recent Developments and Future Plans
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Product and Solutions
2.2.4 Boehringer Ingelheim Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
2.3 Merck Animal Health
2.3.1 Merck Animal Health Details
2.3.2 Merck Animal Health Major Business
2.3.3 Merck Animal Health Companion Animal Pharmaceutical Product and Solutions
2.3.4 Merck Animal Health Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Animal Health Recent Developments and Future Plans
2.4 Elanco Animal Health
2.4.1 Elanco Animal Health Details
2.4.2 Elanco Animal Health Major Business
2.4.3 Elanco Animal Health Companion Animal Pharmaceutical Product and Solutions
2.4.4 Elanco Animal Health Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Elanco Animal Health Recent Developments and Future Plans
2.5 Bayer Animal Health
2.5.1 Bayer Animal Health Details
2.5.2 Bayer Animal Health Major Business
2.5.3 Bayer Animal Health Companion Animal Pharmaceutical Product and Solutions
2.5.4 Bayer Animal Health Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bayer Animal Health Recent Developments and Future Plans
2.6 Virbac
2.6.1 Virbac Details
2.6.2 Virbac Major Business
2.6.3 Virbac Companion Animal Pharmaceutical Product and Solutions
2.6.4 Virbac Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Virbac Recent Developments and Future Plans
2.7 Dechra Veterinary Products
2.7.1 Dechra Veterinary Products Details
2.7.2 Dechra Veterinary Products Major Business
2.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Product and Solutions
2.7.4 Dechra Veterinary Products Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Dechra Veterinary Products Recent Developments and Future Plans
2.8 Ceva
2.8.1 Ceva Details
2.8.2 Ceva Major Business
2.8.3 Ceva Companion Animal Pharmaceutical Product and Solutions
2.8.4 Ceva Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Ceva Recent Developments and Future Plans
2.9 Vetoquinol
2.9.1 Vetoquinol Details
2.9.2 Vetoquinol Major Business
2.9.3 Vetoquinol Companion Animal Pharmaceutical Product and Solutions
2.9.4 Vetoquinol Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Vetoquinol Recent Developments and Future Plans
2.10 Meiji
2.10.1 Meiji Details
2.10.2 Meiji Major Business
2.10.3 Meiji Companion Animal Pharmaceutical Product and Solutions
2.10.4 Meiji Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Meiji Recent Developments and Future Plans
2.11 Ouro Fino Saude
2.11.1 Ouro Fino Saude Details
2.11.2 Ouro Fino Saude Major Business
2.11.3 Ouro Fino Saude Companion Animal Pharmaceutical Product and Solutions
2.11.4 Ouro Fino Saude Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Ouro Fino Saude Recent Developments and Future Plans
2.12 Parnell
2.12.1 Parnell Details
2.12.2 Parnell Major Business
2.12.3 Parnell Companion Animal Pharmaceutical Product and Solutions
2.12.4 Parnell Companion Animal Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Parnell Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Animal Pharmaceutical Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Companion Animal Pharmaceutical Players Market Share
3.2.2 Top 10 Companion Animal Pharmaceutical Players Market Share
3.2.3 Market Competition Trend
3.3 Companion Animal Pharmaceutical Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Animal Pharmaceutical Revenue and Market Share by Type (2016-2021)
4.2 Global Companion Animal Pharmaceutical Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Companion Animal Pharmaceutical Revenue Market Share by Application (2016-2021)
5.2 Companion Animal Pharmaceutical Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Companion Animal Pharmaceutical Revenue by Type (2016-2026)
6.2 North America Companion Animal Pharmaceutical Revenue by Application (2016-2026)
6.3 North America Companion Animal Pharmaceutical Market Size by Country
6.3.1 North America Companion Animal Pharmaceutical Revenue by Country (2016-2026)
6.3.2 United States Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
6.3.3 Canada Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
6.3.4 Mexico Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Animal Pharmaceutical Revenue by Type (2016-2026)
7.2 Europe Companion Animal Pharmaceutical Revenue by Application (2016-2026)
7.3 Europe Companion Animal Pharmaceutical Market Size by Country
7.3.1 Europe Companion Animal Pharmaceutical Revenue by Country (2016-2026)
7.3.2 Germany Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
7.3.3 France Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
7.3.5 Russia Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
7.3.6 Italy Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Animal Pharmaceutical Revenue by Type (2016-2026)
8.2 Asia-Pacific Companion Animal Pharmaceutical Revenue by Application (2016-2026)
8.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region
8.3.1 Asia-Pacific Companion Animal Pharmaceutical Revenue by Region (2016-2026)
8.3.2 China Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
8.3.3 Japan Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
8.3.4 South Korea Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
8.3.5 India Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
8.3.7 Australia Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Companion Animal Pharmaceutical Revenue by Type (2016-2026)
9.2 South America Companion Animal Pharmaceutical Revenue by Application (2016-2026)
9.3 South America Companion Animal Pharmaceutical Market Size by Country
9.3.1 South America Companion Animal Pharmaceutical Revenue by Country (2016-2026)
9.3.2 Brazil Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
9.3.3 Argentina Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Animal Pharmaceutical Revenue by Type (2016-2026)
10.2 Middle East & Africa Companion Animal Pharmaceutical Revenue by Application (2016-2026)
10.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country
10.3.1 Middle East & Africa Companion Animal Pharmaceutical Revenue by Country (2016-2026)
10.3.2 Turkey Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
10.3.4 UAE Companion Animal Pharmaceutical Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Companion Animal Pharmaceutical Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Companion Animal Pharmaceutical Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Companion Animal Pharmaceutical Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Companion Animal Pharmaceutical Revenue (USD Million) by Region (2016-2021)
Table 5. Global Companion Animal Pharmaceutical Revenue Market Share by Region (2021-2026)
Table 6. Zoetis Corporate Information, Head Office, and Major Competitors
Table 7. Zoetis Major Business
Table 8. Zoetis Companion Animal Pharmaceutical Product and Solutions
Table 9. Zoetis Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Companion Animal Pharmaceutical Product and Solutions
Table 13. Boehringer Ingelheim Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Animal Health Corporate Information, Head Office, and Major Competitors
Table 15. Merck Animal Health Major Business
Table 16. Merck Animal Health Companion Animal Pharmaceutical Product and Solutions
Table 17. Merck Animal Health Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Elanco Animal Health Corporate Information, Head Office, and Major Competitors
Table 19. Elanco Animal Health Major Business
Table 20. Elanco Animal Health Companion Animal Pharmaceutical Product and Solutions
Table 21. Elanco Animal Health Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bayer Animal Health Corporate Information, Head Office, and Major Competitors
Table 23. Bayer Animal Health Major Business
Table 24. Bayer Animal Health Companion Animal Pharmaceutical Product and Solutions
Table 25. Bayer Animal Health Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Virbac Corporate Information, Head Office, and Major Competitors
Table 27. Virbac Major Business
Table 28. Virbac Companion Animal Pharmaceutical Product and Solutions
Table 29. Virbac Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Dechra Veterinary Products Corporate Information, Head Office, and Major Competitors
Table 31. Dechra Veterinary Products Major Business
Table 32. Dechra Veterinary Products Companion Animal Pharmaceutical Product and Solutions
Table 33. Dechra Veterinary Products Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Ceva Corporate Information, Head Office, and Major Competitors
Table 35. Ceva Major Business
Table 36. Ceva Companion Animal Pharmaceutical Product and Solutions
Table 37. Ceva Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 39. Vetoquinol Major Business
Table 40. Vetoquinol Companion Animal Pharmaceutical Product and Solutions
Table 41. Vetoquinol Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Meiji Corporate Information, Head Office, and Major Competitors
Table 43. Meiji Major Business
Table 44. Meiji Companion Animal Pharmaceutical Product and Solutions
Table 45. Meiji Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Ouro Fino Saude Corporate Information, Head Office, and Major Competitors
Table 47. Ouro Fino Saude Major Business
Table 48. Ouro Fino Saude Companion Animal Pharmaceutical Product and Solutions
Table 49. Ouro Fino Saude Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Parnell Corporate Information, Head Office, and Major Competitors
Table 51. Parnell Major Business
Table 52. Parnell Companion Animal Pharmaceutical Product and Solutions
Table 53. Parnell Companion Animal Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Companion Animal Pharmaceutical Revenue (USD Million) by Players (2019-2021)
Table 55. Global Companion Animal Pharmaceutical Revenue Share by Players (2019-2021)
Table 56. Breakdown of Companion Animal Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Companion Animal Pharmaceutical Players Head Office, Products and Services Provided
Table 58. Companion Animal Pharmaceutical Mergers & Acquisitions in the Past Five Years
Table 59. Companion Animal Pharmaceutical New Entrants and Expansion Plans
Table 60. Global Companion Animal Pharmaceutical Revenue (USD Million) by Type (2016-2021)
Table 61. Global Companion Animal Pharmaceutical Revenue Share by Type (2016-2021)
Table 62. Global Companion Animal Pharmaceutical Revenue Forecast by Type (2021-2026)
Table 63. Global Companion Animal Pharmaceutical Revenue by Application (2016-2021)
Table 64. Global Companion Animal Pharmaceutical Revenue Forecast by Application (2021-2026)
Table 65. North America Companion Animal Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Companion Animal Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Companion Animal Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Companion Animal Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Companion Animal Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Companion Animal Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Companion Animal Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Companion Animal Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Companion Animal Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Companion Animal Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Companion Animal Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Companion Animal Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Companion Animal Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Companion Animal Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Companion Animal Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Companion Animal Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Companion Animal Pharmaceutical Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Companion Animal Pharmaceutical Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Companion Animal Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Companion Animal Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Companion Animal Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Companion Animal Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Companion Animal Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Companion Animal Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Companion Animal Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Companion Animal Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Companion Animal Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Companion Animal Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Companion Animal Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Companion Animal Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Companion Animal Pharmaceutical Picture
Figure 2. Global Companion Animal Pharmaceutical Revenue Market Share by Indication in 2020
Figure 3. Infectious Diseases
Figure 4. Dermatologic Diseases
Figure 5. Pain
Figure 6. Orthopedic Diseases
Figure 7. Behavioral Diseases
Figure 8. Other Indications
Figure 9. Companion Animal Pharmaceutical Revenue Market Share by Application in 2020
Figure 10. Dogs Picture
Figure 11. Cats Picture
Figure 12. Other Picture
Figure 13. Global Companion Animal Pharmaceutical Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Companion Animal Pharmaceutical Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Companion Animal Pharmaceutical Revenue Market Share by Region (2016-2026)
Figure 16. Global Companion Animal Pharmaceutical Revenue Market Share by Region in 2020
Figure 17. North America Companion Animal Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Companion Animal Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Companion Animal Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Companion Animal Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Companion Animal Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Companion Animal Pharmaceutical Market Drivers
Figure 23. Companion Animal Pharmaceutical Market Restraints
Figure 24. Companion Animal Pharmaceutical Market Trends
Figure 25. Zoetis Recent Developments and Future Plans
Figure 26. Boehringer Ingelheim Recent Developments and Future Plans
Figure 27. Merck Animal Health Recent Developments and Future Plans
Figure 28. Elanco Animal Health Recent Developments and Future Plans
Figure 29. Bayer Animal Health Recent Developments and Future Plans
Figure 30. Virbac Recent Developments and Future Plans
Figure 31. Dechra Veterinary Products Recent Developments and Future Plans
Figure 32. Ceva Recent Developments and Future Plans
Figure 33. Vetoquinol Recent Developments and Future Plans
Figure 34. Meiji Recent Developments and Future Plans
Figure 35. Ouro Fino Saude Recent Developments and Future Plans
Figure 36. Parnell Recent Developments and Future Plans
Figure 37. Global Companion Animal Pharmaceutical Revenue Share by Players in 2020
Figure 38. Companion Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Companion Animal Pharmaceutical Revenue Market Share in 2020
Figure 40. Global Top 10 Players Companion Animal Pharmaceutical Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Companion Animal Pharmaceutical Revenue Share by Type in 2020
Figure 43. Global Companion Animal Pharmaceutical Market Share Forecast by Type (2021-2026)
Figure 44. Global Companion Animal Pharmaceutical Revenue Share by Application in 2020
Figure 45. Global Companion Animal Pharmaceutical Market Share Forecast by Application (2021-2026)
Figure 46. North America Companion Animal Pharmaceutical Sales Market Share by Type (2016-2026)
Figure 47. North America Companion Animal Pharmaceutical Sales Market Share by Application (2016-2026)
Figure 48. North America Companion Animal Pharmaceutical Revenue Market Share by Country (2016-2026)
Figure 49. United States Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Companion Animal Pharmaceutical Sales Market Share by Type (2016-2026)
Figure 53. Europe Companion Animal Pharmaceutical Sales Market Share by Application (2016-2026)
Figure 54. Europe Companion Animal Pharmaceutical Revenue Market Share by Country (2016-2026)
Figure 55. Germany Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Companion Animal Pharmaceutical Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Companion Animal Pharmaceutical Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Companion Animal Pharmaceutical Revenue Market Share by Region (2016-2026)
Figure 63. China Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Companion Animal Pharmaceutical Sales Market Share by Type (2016-2026)
Figure 70. South America Companion Animal Pharmaceutical Sales Market Share by Application (2016-2026)
Figure 71. South America Companion Animal Pharmaceutical Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Companion Animal Pharmaceutical Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Companion Animal Pharmaceutical Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Companion Animal Pharmaceutical Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Companion Animal Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source